Propoven 2% May Join Your Sedative List Due to COVID-19

A new double-strength propofol may hit your shelves...to help meet demand during the COVID-19 pandemic.

It’s because more patients are requiring sedation due to mechanical ventilation for COVID-19...and regular propofol and other sedatives (midazolam, etc) have been in short supply.

“Double-strength” means the product is propofol 2%, or 20 mg/mL...compared to regular propofol, which is 1%, or 10 mg/mL.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals